Published in Cell on October 14, 2011
A long noncoding RNA controls muscle differentiation by functioning as a competing endogenous RNA. Cell (2011) 9.24
Natural RNA circles function as efficient microRNA sponges. Nature (2013) 8.93
The functions and regulation of the PTEN tumour suppressor. Nat Rev Mol Cell Biol (2012) 7.32
Regulatory networks defining EMT during cancer initiation and progression. Nat Rev Cancer (2013) 6.13
Long non-coding RNAs: new players in cell differentiation and development. Nat Rev Genet (2013) 5.48
MicroRNAs and their targets: recognition, regulation and an emerging reciprocal relationship. Nat Rev Genet (2012) 5.38
starBase v2.0: decoding miRNA-ceRNA, miRNA-ncRNA and protein-RNA interaction networks from large-scale CLIP-Seq data. Nucleic Acids Res (2013) 4.33
Expressed pseudogenes in the transcriptional landscape of human cancers. Cell (2012) 4.22
The multilayered complexity of ceRNA crosstalk and competition. Nature (2014) 4.15
Diversifying microRNA sequence and function. Nat Rev Mol Cell Biol (2013) 3.80
MicroRNAs in cancer. Annu Rev Pathol (2013) 3.50
Assessing the ceRNA hypothesis with quantitative measurements of miRNA and target abundance. Mol Cell (2014) 2.83
Melanoma: from mutations to medicine. Genes Dev (2012) 2.59
Transcriptome-wide miR-155 binding map reveals widespread noncanonical microRNA targeting. Mol Cell (2012) 2.54
Retracted HMGA2 functions as a competing endogenous RNA to promote lung cancer progression. Nature (2013) 2.47
LncRNA loc285194 is a p53-regulated tumor suppressor. Nucleic Acids Res (2013) 2.38
A microRNA superfamily regulates nucleotide binding site-leucine-rich repeats and other mRNAs. Plant Cell (2012) 2.32
Integrated transcriptional and competitive endogenous RNA networks are cross-regulated in permissive molecular environments. Proc Natl Acad Sci U S A (2013) 2.13
Abrogation of BRAFV600E-induced senescence by PI3K pathway activation contributes to melanomagenesis. Genes Dev (2012) 2.06
DNMT1-interacting RNAs block gene-specific DNA methylation. Nature (2013) 2.04
Regulation of eukaryotic gene expression by the untranslated gene regions and other non-coding elements. Cell Mol Life Sci (2012) 1.96
microRNA regulatory network inference identifies miR-34a as a novel regulator of TGF-β signaling in glioblastoma. Cancer Discov (2012) 1.94
Regulation of mammalian cell differentiation by long non-coding RNAs. EMBO Rep (2012) 1.82
ceRNA cross-talk in cancer: when ce-bling rivalries go awry. Cancer Discov (2013) 1.74
Aberrant regulation and function of microRNAs in cancer. Curr Biol (2014) 1.72
BRAF inhibitor resistance mediated by the AKT pathway in an oncogenic BRAF mouse melanoma model. Proc Natl Acad Sci U S A (2015) 1.67
Long Noncoding RNAs in Cancer Pathways. Cancer Cell (2016) 1.63
Negative regulation of lncRNA GAS5 by miR-21. Cell Death Differ (2013) 1.60
Functional interactions among microRNAs and long noncoding RNAs. Semin Cell Dev Biol (2014) 1.55
Mutations in regulators of the epigenome and their connections to global chromatin patterns in cancer. Nat Rev Genet (2013) 1.53
Long noncoding RNA associated-competing endogenous RNAs in gastric cancer. Sci Rep (2014) 1.50
Long non-coding RNA HNF1A-AS1 regulates proliferation and migration in oesophageal adenocarcinoma cells. Gut (2013) 1.48
MicroRNAs as a selective channel of communication between competing RNAs: a steady-state theory. Biophys J (2013) 1.35
MicroRNA control of epithelial-mesenchymal transition and metastasis. Cancer Metastasis Rev (2012) 1.34
Long non-coding RNAs: versatile master regulators of gene expression and crucial players in cancer. Am J Transl Res (2012) 1.33
Long noncoding RNA CCAT1 promotes hepatocellular carcinoma progression by functioning as let-7 sponge. J Exp Clin Cancer Res (2015) 1.28
PTEN at a glance. J Cell Sci (2012) 1.26
Uncovering the role of genomic "dark matter" in human disease. J Clin Invest (2012) 1.26
Control of cholesterol metabolism and plasma high-density lipoprotein levels by microRNA-144. Circ Res (2013) 1.25
Oncogenic miR-181a/b affect the DNA damage response in aggressive breast cancer. Cell Cycle (2013) 1.23
General principals of miRNA biogenesis and regulation in the brain. Neuropsychopharmacology (2012) 1.23
MicroRNA-93 activates c-Met/PI3K/Akt pathway activity in hepatocellular carcinoma by directly inhibiting PTEN and CDKN1A. Oncotarget (2015) 1.22
Regulation of metabolism by long, non-coding RNAs. Front Genet (2014) 1.21
Modelling Competing Endogenous RNA Networks. PLoS One (2013) 1.21
Genome-wide screening and functional analysis identify a large number of long noncoding RNAs involved in the sexual reproduction of rice. Genome Biol (2014) 1.18
microRNA-9 targets the long non-coding RNA MALAT1 for degradation in the nucleus. Sci Rep (2013) 1.18
Pathways and therapeutic targets in melanoma. Oncotarget (2014) 1.17
Competing endogenous RNA: the key to posttranscriptional regulation. ScientificWorldJournal (2014) 1.17
Endogenous microRNA sponges: evidence and controversy. Nat Rev Genet (2016) 1.15
Polyadenylation-dependent control of long noncoding RNA expression by the poly(A)-binding protein nuclear 1. PLoS Genet (2012) 1.15
MicroRNAs in autophagy and their emerging roles in crosstalk with apoptosis. Autophagy (2012) 1.10
Life in the fast lane: mammalian disease models in the genomics era. Cell (2012) 1.08
Clinical applications of microRNAs. F1000Res (2013) 1.07
Long noncoding RNAs in innate and adaptive immunity. Curr Opin Immunol (2013) 1.06
Epithelial-mesenchymal transition is regulated at post-transcriptional levels by transforming growth factor-β signaling during tumor progression. Cancer Sci (2015) 1.05
"Snorkeling" for missing players in cancer. J Clin Invest (2012) 1.05
Emerging roles of circRNA_001569 targeting miR-145 in the proliferation and invasion of colorectal cancer. Oncotarget (2016) 1.04
Competing endogenous RNA database. Bioinformation (2012) 1.03
Noncoding RNA in oncogenesis: a new era of identifying key players. Int J Mol Sci (2013) 1.03
microRNA control of mouse and human pluripotent stem cell behavior. Annu Rev Cell Dev Biol (2013) 1.02
Competing endogenous RNA networks: tying the essential knots for cancer biology and therapeutics. J Hematol Oncol (2015) 1.01
Emerging roles of competing endogenous RNAs in cancer: insights from the regulation of PTEN. Mol Cell Biol (2013) 1.01
mRNA-mRNA duplexes that autoelicit Staufen1-mediated mRNA decay. Nat Struct Mol Biol (2013) 1.01
ceRNAs: miRNA target mimic mimics. Cell (2011) 0.99
lnCeDB: database of human long noncoding RNA acting as competing endogenous RNA. PLoS One (2014) 0.98
The physiological impact of microRNA gene regulation in the retina. Cell Mol Life Sci (2012) 0.98
Epigenetic regulation in human melanoma: past and future. Epigenetics (2015) 0.98
From discovery to function: the expanding roles of long noncoding RNAs in physiology and disease. Endocr Rev (2014) 0.98
MiR-103a-3p targets the 5' UTR of GPRC5A in pancreatic cells. RNA (2014) 0.97
Long noncoding RNA FER1L4 suppresses cancer cell growth by acting as a competing endogenous RNA and regulating PTEN expression. Sci Rep (2015) 0.97
PI(4,5)P2 5-phosphatase A regulates PI3K/Akt signalling and has a tumour suppressive role in human melanoma. Nat Commun (2013) 0.97
Role of MicroRNAs in lung disease. Arch Bronconeumol (2012) 0.96
microRNAs and ceRNAs: RNA networks in pathogenesis of cancer. Chin J Cancer Res (2013) 0.96
Navigating the therapeutic complexity of PI3K pathway inhibition in melanoma. Clin Cancer Res (2013) 0.93
Long non-coding RNAs as regulators of the endocrine system. Nat Rev Endocrinol (2015) 0.93
Focus on PTEN Regulation. Front Oncol (2015) 0.93
Noncoding RNAs involved in mammary gland development and tumorigenesis: there's a long way to go. J Mammary Gland Biol Neoplasia (2012) 0.92
3'UTRs take a long shot in the brain. Bioessays (2013) 0.92
The mRNA related ceRNA-ceRNA landscape and significance across 20 major cancer types. Nucleic Acids Res (2015) 0.92
Wrangling for microRNAs provokes much crosstalk. Genome Biol (2011) 0.91
MicroRNAs as therapeutic targets in human cancers. Wiley Interdiscip Rev RNA (2014) 0.91
All's well that ends well: alternative polyadenylation and its implications for stem cell biology. Curr Opin Cell Biol (2013) 0.91
Roles, Functions, and Mechanisms of Long Non-coding RNAs in Cancer. Genomics Proteomics Bioinformatics (2016) 0.91
Pseudogenes transcribed in breast invasive carcinoma show subtype-specific expression and ceRNA potential. BMC Genomics (2015) 0.91
microRNA-mediated regulation of innate immune response in rheumatic diseases. Arthritis Res Ther (2013) 0.91
LncRNA Expression Discriminates Karyotype and Predicts Survival in B-Lymphoblastic Leukemia. Mol Cancer Res (2015) 0.90
Control by a hair's breadth: the role of microRNAs in the skin. Cell Mol Life Sci (2012) 0.90
Model-guided quantitative analysis of microRNA-mediated regulation on competing endogenous RNAs using a synthetic gene circuit. Proc Natl Acad Sci U S A (2015) 0.90
MicroRNA control of vascular endothelial growth factor signaling output during vascular development. Arterioscler Thromb Vasc Biol (2013) 0.90
Decoy activity through microRNAs: the therapeutic implications. Expert Opin Biol Ther (2012) 0.89
The non-coding transcriptome as a dynamic regulator of cancer metastasis. Cancer Metastasis Rev (2014) 0.89
LncRNA RSU1P2 contributes to tumorigenesis by acting as a ceRNA against let-7a in cervical cancer cells. Oncotarget (2017) 0.89
Quantitative analysis of microRNAs in tissue microarrays by in situ hybridization. Biotechniques (2012) 0.89
Noncoding RNAs: key molecules in understanding and treating pain. Trends Mol Med (2014) 0.89
Long noncoding RNA MIR31HG exhibits oncogenic property in pancreatic ductal adenocarcinoma and is negatively regulated by miR-193b. Oncogene (2015) 0.88
Cancer gene discovery: exploiting insertional mutagenesis. Mol Cancer Res (2013) 0.88
Pseudogene INTS6P1 regulates its cognate gene INTS6 through competitive binding of miR-17-5p in hepatocellular carcinoma. Oncotarget (2015) 0.88
Melanoma cells revive an embryonic transcriptional network to dictate phenotypic heterogeneity. Front Oncol (2014) 0.88
Molecular Functions of Long Non-Coding RNAs in Plants. Genes (Basel) (2012) 0.88
3'UTR shortening identifies high-risk cancers with targeted dysregulation of the ceRNA network. Sci Rep (2014) 0.87
Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell (2005) 96.87
MicroRNAs: target recognition and regulatory functions. Cell (2009) 92.17
Mutations of the BRAF gene in human cancer. Nature (2002) 65.42
MicroRNA targeting specificity in mammals: determinants beyond seed pairing. Mol Cell (2007) 38.42
Most mammalian mRNAs are conserved targets of microRNAs. Genome Res (2008) 37.16
The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat Cell Biol (2008) 24.27
The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2. Genes Dev (2008) 15.01
A coding-independent function of gene and pseudogene mRNAs regulates tumour biology. Nature (2010) 13.82
A ceRNA hypothesis: the Rosetta Stone of a hidden RNA language? Cell (2011) 10.50
The miR-200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2. J Biol Chem (2008) 10.08
High frequency of BRAF mutations in nevi. Nat Genet (2002) 9.95
BRAF and RAS mutations in human lung cancer and melanoma. Cancer Res (2002) 8.55
Braf(V600E) cooperates with Pten loss to induce metastatic melanoma. Nat Genet (2009) 7.81
Cancer gene discovery in solid tumours using transposon-based somatic mutagenesis in the mouse. Nature (2005) 6.40
Oncogenic Braf induces melanocyte senescence and melanoma in mice. Cancer Cell (2009) 4.76
Identification of the miR-106b~25 microRNA cluster as a proto-oncogenic PTEN-targeting intron that cooperates with its host gene MCM7 in transformation. Sci Signal (2010) 4.15
Desperately seeking microRNA targets. Nat Struct Mol Biol (2010) 3.85
Genetic interaction between NRAS and BRAF mutations and PTEN/MMAC1 inactivation in melanoma. J Invest Dermatol (2004) 3.80
SIP1/ZEB2 induces EMT by repressing genes of different epithelial cell-cell junctions. Nucleic Acids Res (2005) 3.41
p53 regulates epithelial-mesenchymal transition through microRNAs targeting ZEB1 and ZEB2. J Exp Med (2011) 2.93
MicroRNAs and their target gene networks in breast cancer. Breast Cancer Res (2010) 2.83
P53 mRNA controls p53 activity by managing Mdm2 functions. Nat Cell Biol (2008) 2.43
A translation-independent role of oskar RNA in early Drosophila oogenesis. Development (2006) 2.11
Pseudogenes in metazoa: origin and features. Brief Funct Genomic Proteomic (2004) 1.99
Expression of versican 3'-untranslated region modulates endogenous microRNA functions. PLoS One (2010) 1.94
Characterization of melanocyte-specific inducible Cre recombinase transgenic mice. Genesis (2006) 1.85
Integrative analysis of epigenetic modulation in melanoma cell response to decitabine: clinical implications. PLoS One (2009) 1.80
MicroRNAs and prostate cancer. Acta Biochim Biophys Sin (Shanghai) (2010) 1.64
microRNA-141 is involved in a nasopharyngeal carcinoma-related genes network. Carcinogenesis (2010) 1.59
MicroRNA-200 family members differentially regulate morphological plasticity and mode of melanoma cell invasion. PLoS One (2010) 1.50
Metrics for comparing regulatory sequences on the basis of pattern counts. Bioinformatics (2004) 1.50
Role of microRNAs in ovarian cancer pathogenesis and potential clinical implications. Int J Biochem Cell Biol (2009) 1.43
An atlas of tissue-specific conserved coexpression for functional annotation and disease gene prediction. Eur J Hum Genet (2011) 1.40
Initial sequencing and comparative analysis of the mouse genome. Nature (2002) 96.15
Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors. N Engl J Med (2002) 24.88
Inhibition of Hedgehog signaling enhances delivery of chemotherapy in a mouse model of pancreatic cancer. Science (2009) 18.40
Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis. Nature (2005) 15.83
Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse. Cancer Cell (2003) 15.43
A pattern-based method for the identification of MicroRNA binding sites and their corresponding heteroduplexes. Cell (2006) 14.70
Trp53R172H and KrasG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in mice. Cancer Cell (2005) 14.21
A coding-independent function of gene and pseudogene mRNAs regulates tumour biology. Nature (2010) 13.82
Exome sequencing identifies frequent mutation of the SWI/SNF complex gene PBRM1 in renal carcinoma. Nature (2011) 13.30
Restoration of p53 function leads to tumour regression in vivo. Nature (2007) 12.62
Inhibition of mTORC1 leads to MAPK pathway activation through a PI3K-dependent feedback loop in human cancer. J Clin Invest (2008) 10.74
Mouse genomic variation and its effect on phenotypes and gene regulation. Nature (2011) 10.66
A ceRNA hypothesis: the Rosetta Stone of a hidden RNA language? Cell (2011) 10.50
Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis. Nature (2011) 9.70
A genomic regulatory network for development. Science (2002) 9.67
Tenets of PTEN tumor suppression. Cell (2008) 8.61
Mutant p53 gain of function in two mouse models of Li-Fraumeni syndrome. Cell (2004) 8.48
Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes. Nature (2012) 8.31
Activated Kras and Ink4a/Arf deficiency cooperate to produce metastatic pancreatic ductal adenocarcinoma. Genes Dev (2003) 8.27
The IFITM proteins mediate cellular resistance to influenza A H1N1 virus, West Nile virus, and dengue virus. Cell (2009) 7.88
Phosphorylation and functional inactivation of TSC2 by Erk implications for tuberous sclerosis and cancer pathogenesis. Cell (2005) 7.75
ATP citrate lyase inhibition can suppress tumor cell growth. Cancer Cell (2005) 7.65
Pten dose dictates cancer progression in the prostate. PLoS Biol (2003) 7.62
The functions and regulation of the PTEN tumour suppressor. Nat Rev Mol Cell Biol (2012) 7.32
Aberrant ERG expression cooperates with loss of PTEN to promote cancer progression in the prostate. Nat Genet (2009) 7.26
Coding-independent regulation of the tumor suppressor PTEN by competing endogenous mRNAs. Cell (2011) 7.02
Exome sequencing identifies recurrent somatic RAC1 mutations in melanoma. Nat Genet (2012) 7.00
Does the ribosome translate cancer? Nat Rev Cancer (2003) 6.89
Essential role for nuclear PTEN in maintaining chromosomal integrity. Cell (2007) 6.52
Systems biology approaches identify ATF3 as a negative regulator of Toll-like receptor 4. Nature (2006) 6.28
The differential effects of mutant p53 alleles on advanced murine lung cancer. Cancer Res (2005) 5.93
Structure, dynamics and functions of promyelocytic leukaemia nuclear bodies. Nat Rev Mol Cell Biol (2007) 5.79
Ubiquitination regulates PTEN nuclear import and tumor suppression. Cell (2007) 5.62
53BP1 loss rescues BRCA1 deficiency and is associated with triple-negative and BRCA-mutated breast cancers. Nat Struct Mol Biol (2010) 5.59
Essential role of Plzf in maintenance of spermatogonial stem cells. Nat Genet (2004) 5.55
Maximizing mouse cancer models. Nat Rev Cancer (2007) 5.38
NEDD4-1 is a proto-oncogenic ubiquitin ligase for PTEN. Cell (2007) 5.20
Overview of BioCreative II gene normalization. Genome Biol (2008) 5.05
The translation factor eIF-4E promotes tumor formation and cooperates with c-Myc in lymphomagenesis. Nat Med (2004) 5.01
Dynamics of the immune reaction to pancreatic cancer from inception to invasion. Cancer Res (2007) 4.95
Bethesda proposals for classification of nonlymphoid hematopoietic neoplasms in mice. Blood (2002) 4.88
Pathology of genetically engineered mouse models of pancreatic exocrine cancer: consensus report and recommendations. Cancer Res (2006) 4.83
Nucleophosmin and cancer. Nat Rev Cancer (2006) 4.82
IFITM3 restricts the morbidity and mortality associated with influenza. Nature (2012) 4.66
GeneWays: a system for extracting, analyzing, visualizing, and integrating molecular pathway data. J Biomed Inform (2004) 4.57
Suppression of antitumor immunity by stromal cells expressing fibroblast activation protein-alpha. Science (2010) 4.56
PLX4032, a selective BRAF(V600E) kinase inhibitor, activates the ERK pathway and enhances cell migration and proliferation of BRAF melanoma cells. Pigment Cell Melanoma Res (2010) 4.50
Nuclear PTEN regulates the APC-CDH1 tumor-suppressive complex in a phosphatase-independent manner. Cell (2011) 4.49
Evidence that inositol polyphosphate 4-phosphatase type II is a tumor suppressor that inhibits PI3K signaling. Cancer Cell (2009) 4.30
Suppression of BRAF(V599E) in human melanoma abrogates transformation. Cancer Res (2003) 4.28
Demonstration of a genetic therapeutic index for tumors expressing oncogenic BRAF by the kinase inhibitor SB-590885. Cancer Res (2006) 4.20
Subtle variations in Pten dose determine cancer susceptibility. Nat Genet (2010) 4.19
Identification of the miR-106b~25 microRNA cluster as a proto-oncogenic PTEN-targeting intron that cooperates with its host gene MCM7 in transformation. Sci Signal (2010) 4.15
The BTB-zinc finger transcriptional regulator PLZF controls the development of invariant natural killer T cell effector functions. Nat Immunol (2008) 4.15
The pancreas cancer microenvironment. Clin Cancer Res (2012) 4.10
Role of nucleophosmin in embryonic development and tumorigenesis. Nature (2005) 4.09
The SUMO pathway is essential for nuclear integrity and chromosome segregation in mice. Dev Cell (2005) 3.96
SUMO modification of Huntingtin and Huntington's disease pathology. Science (2004) 3.85
Stromal biology and therapy in pancreatic cancer. Gut (2010) 3.80
Sox2 deficiency causes neurodegeneration and impaired neurogenesis in the adult mouse brain. Development (2004) 3.75
Role of the proto-oncogene Pokemon in cellular transformation and ARF repression. Nature (2005) 3.75
PML targeting eradicates quiescent leukaemia-initiating cells. Nature (2008) 3.75
SIRT3 opposes reprogramming of cancer cell metabolism through HIF1α destabilization. Cancer Cell (2011) 3.71
Identification of a tumour suppressor network opposing nuclear Akt function. Nature (2006) 3.68
Expression profiling reveals novel pathways in the transformation of melanocytes to melanomas. Cancer Res (2004) 3.64
Function of C/EBPdelta in a regulatory circuit that discriminates between transient and persistent TLR4-induced signals. Nat Immunol (2009) 3.60
The deubiquitinylation and localization of PTEN are regulated by a HAUSP-PML network. Nature (2008) 3.53
PI3K pathway regulates survival of cancer stem cells residing in the perivascular niche following radiation in medulloblastoma in vivo. Genes Dev (2008) 3.50
Sequence-based characterization of structural variation in the mouse genome. Nature (2011) 3.48
A continuum model for tumour suppression. Nature (2011) 3.48
A novel type of cellular senescence that can be enhanced in mouse models and human tumor xenografts to suppress prostate tumorigenesis. J Clin Invest (2010) 3.47
Conditional expression of oncogenic K-ras from its endogenous promoter induces a myeloproliferative disease. J Clin Invest (2004) 3.47
Genome-wide generation and systematic phenotyping of knockout mice reveals new roles for many genes. Cell (2013) 3.47
Somatic activation of oncogenic Kras in hematopoietic cells initiates a rapidly fatal myeloproliferative disorder. Proc Natl Acad Sci U S A (2003) 3.46
Development of Ewing's sarcoma from primary bone marrow-derived mesenchymal progenitor cells. Cancer Res (2005) 3.33
A PML–PPAR-δ pathway for fatty acid oxidation regulates hematopoietic stem cell maintenance. Nat Med (2012) 3.33
The role of PML in tumor suppression. Cell (2002) 3.28
Large-scale mutagenesis in p19(ARF)- and p53-deficient mice identifies cancer genes and their collaborative networks. Cell (2008) 3.25
A murine lung cancer co-clinical trial identifies genetic modifiers of therapeutic response. Nature (2012) 3.24
The deubiquitinase USP9X suppresses pancreatic ductal adenocarcinoma. Nature (2012) 3.23
Cannabinoid action induces autophagy-mediated cell death through stimulation of ER stress in human glioma cells. J Clin Invest (2009) 3.23
The mechanisms of PML-nuclear body formation. Mol Cell (2006) 3.22
PML regulates apoptosis at endoplasmic reticulum by modulating calcium release. Science (2010) 3.21
Dyskeratosis congenita and cancer in mice deficient in ribosomal RNA modification. Science (2003) 3.18
Loss of the tumor suppressor PML in human cancers of multiple histologic origins. J Natl Cancer Inst (2004) 3.17
Hyaluronan impairs vascular function and drug delivery in a mouse model of pancreatic cancer. Gut (2012) 3.13